Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2026-02-09 Report Publication Anno…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
Navamedic ASA: Invitation to presentation of fourth quarter 2025 results
Report Publication Announcement Classification · 95% confidence The document is an invitation to a presentation of financial results, not the results themselves. It is short (1126 characters), provides a date and location for an upcoming event, and serves as an announcement regarding the release of information. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2026-02-09 English
Financial calendar
Report Publication Announcement Classification · 98% confidence The document is a 'Financial calendar' listing future dates for the release of various reports (Quarterly, Annual) and the Annual General Meeting. It does not contain the actual financial data or reports themselves, but rather serves as an announcement of the schedule for upcoming publications. According to the 'Menu vs Meal' rule, an announcement regarding the timing or release of reports is classified as a Report Publication Announcement (RPA).
2026-01-19 English
Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership and a new product launch ('Lettere steg') between Navamedic ASA and Grete Roede AS. It describes the nature of the collaboration, the target market, and the expected launch timeline. As it is a general corporate announcement regarding business operations and partnerships that does not fit into specific financial reporting categories like earnings, dividends, or regulatory filings, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-12-29 Norwegian
Financial calendar
Report Publication Announcement Classification · 99% confidence The document is a 'Financial calendar' listing future dates for the release of various reports (Quarterly, Half-yearly, Annual) and the Annual General Meeting. It does not contain the actual financial data or reports themselves, but rather serves as a schedule announcement. According to the 'Menu vs Meal' rule, announcements regarding the timing or publication of reports are classified as Report Publication Announcements (RPA).
2025-12-18 English
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026 - Attachment: NAVA_Notice_of_EGM_12_December_2025.pdf
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official 'Notice of Extraordinary General Meeting' (Innkalling til ekstraordinær generalforsamling) for Navamedic ASA. It contains the agenda, voting procedures, proxy forms, and registration details for shareholders. This document is a solicitation of shareholder participation and voting for an upcoming meeting, which falls under the category of Proxy Solicitation & Information Statement.
2025-12-12 Norwegian
Navamedic ASA: Notice of extraordinary general meeting on 7 January 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for Navamedic ASA. It provides the date, location, and purpose of the meeting (amending the board composition) and includes instructions for shareholder voting and proxy submission. As it is a document sent to shareholders to provide information and request votes for a meeting, it falls under the Proxy Solicitation & Information Statement category.
2025-12-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.